Oncology Antibiotics

Laboratory-produced drugs used to target and destroy cancerous cells. Therapeutic anticancer antibiotics have become an accepted treatment for certain types of cancer. These drugs bind specifically to primary and metastatic cancer cells to block cell growth, while limiting effects on surrounding healthy cells. Antibiotic medicines kill malignant cells by fragmenting the DNA in the cell nucleus and by oxidizing critical compounds the cells need.   

For patients receiving chemotherapy, there is an increased risk of infection due to a low white blood cell count (neutropenia) caused by a toxic effect of chemotherapy on the bone marrow. Preventive antibiotic therapy before the development of fever prevents illness and death in people with a low white blood cell count after chemotherapy.

 

  • Anticancer Antibiotics
  • Role of Antibiotics in Killing Cancer Stem Cells
  • Antibiotics for Anti-Cancer Therapy(FDA-Approved)
  • Antibiotics Against Lung Cancer Cells
  • Can Antibiotics Increase the Risk of Cancer?
  • Antibiotics in Breast Cancer Treatment
  • Antibiotics in Acne Treatment

Related Conference of Oncology Antibiotics

March 04-05, 2019

10th Molecular Immunology & Immunogenetics Congress

Barcelona, Spain
March 18-19, 2019

11th Global Summit on Immunology and Cell Biology

Sydney, Australia
March 18-19, 2019

13th International Congress on Autoimmunity

Brisbane, Australia
June 13-14, 2019 |

10th European Immunology Conference

Berlin, Germany
July 24-25, 2019

11th World Congress and Expo on Immunology

Vancouver, Canada
July 29-30 2019

6th International Conference on Parasitology & Microbiology

Amsterdam, Netherlands
October 21-22, 2019

12th Annual Congress on Immunology & Immunogenetics

Rome, Italy
November 22-23, 2019 |

World Conference on Vaccine and Immunology

Dubai, UAE

Oncology Antibiotics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in